documents: FDA-2023-N-1661-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2023-N-1661-0001 | FDA | FDA-2023-N-1661 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Expanded Access to Investigational Drugs for Treatment Use | Notice | 30 Day Proposed Information Collection | 2023-05-10T04:00:00Z | 2023 | 5 | 2023-05-10T04:00:00Z | 2023-06-10T03:59:59Z | 2023-07-17T19:52:50Z | 2023-09982 | 0 | 0 | 09000064859ed40b |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref